This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AstraZeneca PLC (AZN)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 24.71B 26.09B 25.71B 27.97B
Cost of Sales 1.79B 2.56B 678.00M 2.88B
Gross Operating Profit 22.91B 23.54B 25.03B 25.10B
Selling, General, and Administrative Expenses 11.11B 13.32B 12.51B 10.16B
Research & Development 6.00B 5.58B 4.82B 5.24B
Operating Income before D & A (EBITDA) 5.80B 4.63B 7.70B 9.70B
Depreciation & Amortization 2.85B 3.28B 4.58B 2.52B
Interest Income 46.00M 0.00 50.00M 528.00M
Other Income - Net -339.00M -508.00M 595.00M 970.00M
Special Income / Charges 1.50B 787.00M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 4.14B 1.63B 3.76B 8.68B
Interest Expense 1.07B 383.00M 495.00M 958.00M
Pre-Tax Income 3.07B 1.25B 3.27B 7.72B
Income Taxes 243.00M 11.00M 696.00M 1.39B
Minority Interest 1.00M 2.00M 15.00M 30.00M
Net Income From Continuing Operations 2.83B 1.24B 2.57B 6.33B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.83B 1.24B 2.57B 6.33B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.83B 1.23B 2.56B 6.30B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.33B 448.00M 2.57B 6.33B
Preferred Dividends
Net Income Available To Common 0.00 1.24B 2.57B 6.33B
Basic EPS from Continuing Ops. 1.12 0.49 1.02 2.50
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.12 0.49 1.02 2.50
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.12 0.49 1.02 2.50
Basic Normalized Net Income/Share 0.52 0.18 1.02 2.50
EPS fr Continuing Ops. 1.12 0.49 1.02 2.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.12 0.49 1.02 2.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.12 0.49 1.02 2.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.52 0.18 1.02 2.49
Dividends Paid per Share 1.40 1.40 1.40 1.43
AZN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for AZN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 3
Moderate Buy 0 0 0 0
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
GET AZN ANALYST REPORT

AZN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs